Compare MCD & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCD | TMO |
|---|---|---|
| Founded | 1940 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.3B | 191.5B |
| IPO Year | 1995 | 1996 |
| Metric | MCD | TMO |
|---|---|---|
| Price | $331.21 | $507.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 26 | 19 |
| Target Price | $340.12 | ★ $639.83 |
| AVG Volume (30 Days) | ★ 3.3M | 2.1M |
| Earning Date | 05-14-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.22% | 0.34% |
| EPS Growth | 4.92 | ★ 7.32 |
| EPS | 11.95 | ★ 17.74 |
| Revenue | ★ $26,885,000,000.00 | $20,918,000,000.00 |
| Revenue This Year | $8.35 | $6.17 |
| Revenue Next Year | $5.73 | $5.21 |
| P/E Ratio | ★ $28.06 | $28.64 |
| Revenue Growth | 3.72 | ★ 14.47 |
| 52 Week Low | $283.47 | $385.46 |
| 52 Week High | $341.75 | $643.99 |
| Indicator | MCD | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 56.88 | 31.21 |
| Support Level | $295.03 | $493.64 |
| Resistance Level | $335.67 | $549.44 |
| Average True Range (ATR) | 5.94 | 13.30 |
| MACD | -0.03 | 1.34 |
| Stochastic Oscillator | 51.20 | 31.20 |
McDonald's is the world's largest restaurant brand, with nearly $131 billion in systemwide sales across more than 44,000 restaurants and over 100 markets. The quick-service chain built its early reputation on speed, consistency, and affordable hamburgers, and today its global menu spans burgers, chicken, breakfast, and beverages that have helped popularize American fast-food cuisine worldwide. The firm derives the bulk of its revenue from franchise royalties and rent (about 61%), with the remainder stemming from company-operated restaurants across three segments: the United States (41% of systemwide sales), international operated markets (34%), and international developmental/licensed markets (25%).
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).